Randhawa Simrat bought DNTH
November 14, 2025 · Form 4 insider transaction
Randhawa Simrat bought 31,250 shares of Dianthus Therapeutics, Inc. at $22.07 per share, a transaction worth $689.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
31,250
Price
$22.07
Total value
$689.7K
InsiderRandhawa Simrat
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 14, 2025
Filing dateNovember 14, 2025
Shares owned after113,031
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.